Next Century Growth Investors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-8,726
Closed -$1.79M 112
2022
Q4
$1.79M Sell
8,726
-10,752
-55% -$2.72M 0.22% 84
2022
Q3
$5.42M Sell
19,478
-94
-0.5% -$23.9K 0.66% 47
2022
Q2
$3.74M Sell
19,572
-5,577
-22% -$984K 0.49% 56
2022
Q1
$5.21M Buy
25,149
+5,161
+26% +$851K 0.52% 59
2021
Q4
$3.56M Sell
19,988
-7,327
-27% -$1.45M 0.32% 84
2021
Q3
$5.62M Buy
27,315
+8,459
+45% +$1.66M 0.49% 63
2021
Q2
$3.58M Sell
18,856
-3,288
-15% -$538K 0.28% 91
2021
Q1
$2.88M Sell
22,144
-86,968
-80% -$10.4M 0.22% 103
2020
Q4
$11.3M Sell
109,112
-65,192
-37% -$5.65M 0.95% 33
2020
Q3
$13.2M Sell
174,304
-28,091
-14% -$1.59M 1.37% 22
2020
Q2
$9.59M Buy
+202,395
New +$8.34M 1.09% 35

Other funds holding SWAV

Next Century Growth Investors's SWAV Position: Q1 2023 in Review

Next Century Growth Investors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2023, closing a stake of 8,726 shares — an estimated $1.79M sold.

Next Century Growth Investors first reported a position in SWAV in Q2 2020 and held it in 11 quarters. The position peaked at $13.2M in Q3 2020. 381 funds tracked by Wall St. Rank hold SWAV as of Q1 2023.

  • Next Century Growth Investors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Next Century Growth Investors sold 8,726 Shockwave Medical, Inc. Common Stock shares in Q1 2023, an estimated $1.79M.
  • Next Century Growth Investors first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2020 and held it in 11 quarters.
  • Next Century Growth Investors's Shockwave Medical, Inc. Common Stock position peaked at $13.2M in Q3 2020.
  • 381 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2023.

Based on Next Century Growth Investors's 13F filing for Q1 2023, filed 12 May 2023.